Nuveen Asset Management LLC Grows Holdings in USANA Health Sciences, Inc. (NYSE:USNA)


Share on StockTwits

Nuveen Asset Management LLC increased its position in shares of USANA Health Sciences, Inc. (NYSE:USNA) by 6.6% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 145,410 shares of the company’s stock after buying an additional 9,060 shares during the period. Nuveen Asset Management LLC’s holdings in USANA Health Sciences were worth $11,212,000 at the end of the most recent reporting period.

A number of other institutional investors have also recently added to or reduced their stakes in USNA. Vantage Consulting Group Inc purchased a new stake in USANA Health Sciences during the 4th quarter worth $29,000. Point72 Hong Kong Ltd purchased a new stake in USANA Health Sciences during the 3rd quarter worth $30,000. Veriti Management LLC purchased a new stake in USANA Health Sciences during the 4th quarter worth $30,000. ProShare Advisors LLC purchased a new stake in USANA Health Sciences during the 4th quarter worth $215,000. Finally, Virginia Retirement Systems ET AL purchased a new stake in USANA Health Sciences during the 4th quarter worth $231,000. 54.12% of the stock is currently owned by hedge funds and other institutional investors.

USNA opened at $100.63 on Tuesday. The company has a 50-day moving average of $98.41 and a 200-day moving average of $84.37. The company has a market capitalization of $2.08 billion, a P/E ratio of 18.64, a PEG ratio of 0.96 and a beta of 0.98. USANA Health Sciences, Inc. has a 1-year low of $65.00 and a 1-year high of $102.58.

USANA Health Sciences (NYSE:USNA) last released its earnings results on Monday, February 8th. The company reported $1.87 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $1.39 by $0.48. The company had revenue of $310.50 million during the quarter, compared to the consensus estimate of $286.71 million. USANA Health Sciences had a net margin of 10.57% and a return on equity of 32.91%. The company’s revenue was up 14.4% on a year-over-year basis. During the same quarter in the previous year, the firm earned $1.41 EPS. As a group, sell-side analysts expect that USANA Health Sciences, Inc. will post 5.4 earnings per share for the current year.

USANA Health Sciences declared that its board has initiated a share repurchase plan on Tuesday, February 9th that permits the company to buyback $150.00 million in shares. This buyback authorization permits the company to purchase up to 8.2% of its shares through open market purchases. Shares buyback plans are generally a sign that the company’s leadership believes its stock is undervalued.

Several equities research analysts recently issued reports on the stock. Roth Capital lifted their price target on shares of USANA Health Sciences from $107.00 to $126.00 and gave the stock a “buy” rating in a research note on Wednesday, February 10th. They noted that the move was a valuation call. Zacks Investment Research raised shares of USANA Health Sciences from a “hold” rating to a “buy” rating and set a $98.00 target price for the company in a research report on Thursday, February 11th.

In related news, Director Gilbert A. Fuller sold 426 shares of the business’s stock in a transaction dated Tuesday, February 16th. The shares were sold at an average price of $91.54, for a total transaction of $38,996.04. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, insider Kevin Guest sold 12,515 shares of the business’s stock in a transaction dated Wednesday, February 24th. The shares were sold at an average price of $95.00, for a total transaction of $1,188,925.00. Following the sale, the insider now directly owns 13,065 shares of the company’s stock, valued at approximately $1,241,175. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 45,340 shares of company stock valued at $4,256,473. Insiders own 45.40% of the company’s stock.

USANA Health Sciences Company Profile

USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional and personal care products. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers comprising targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and foods that include meal replacement shakes, snack bars, and other related products, which provide macro-nutrition.

Read More: What is an Initial Coin Offering (ICO)?

Want to see what other hedge funds are holding USNA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for USANA Health Sciences, Inc. (NYSE:USNA).

Institutional Ownership by Quarter for USANA Health Sciences (NYSE:USNA)

Receive News & Ratings for USANA Health Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for USANA Health Sciences and related companies with MarketBeat.com's FREE daily email newsletter.